Xerapeutics AB

ABActive

Org 5594006636Vallvägen 4 A, 756 51 UppsalaResearch and experimental development on natural sciences and engineering· NACE 7210Est. 2022 · 3 years old1-4 employees

Overview Financials People & ownership Related companies

Xerapeutics AB is a Swedish AB based in Uppsala, operating in the Research and experimental development on natural sciences and engineering sector. Incorporated in 2022, the company reported revenue of SEK 1 in its latest annual filing.

Revenue 2025

SEK 1

EBITDA margin

-292815200.0%

Net profit 2025

SEK -2,9M

Key ratios

See full ratios →

71.5%

This company

20232025

3.5×

This company

20232025

-99.8%

This company

20232025

EBITDA — year on year

SEK millions

Key figures

Annual report 2025

Revenue	SEK 1	—
EBITDA	SEK -2,9M	—
Net profit	SEK -2,9M	—
Total assets	SEK 2,9M	+11633%
Equity	SEK 2,1M	+8291%
Employees	—	—

Contact

Address

Vallvägen 4 A, 756 51 Uppsala

Risika for professionals

Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.

Visit risika.com

Frequently asked questions

What is the Org number of Xerapeutics AB?

Xerapeutics AB is registered with Bolagsverket / SCB under Org 5594006636.

What is the revenue of Xerapeutics AB?

Xerapeutics AB reported revenue of SEK 1 in 2025.

Who is the CEO of Xerapeutics AB?

Håkan Gunnar Engqvist is the CEO of Xerapeutics AB.

Who is the chairman of Xerapeutics AB?

Jonas Göran Ekblom chairs the board of Xerapeutics AB, in role since 2025.

Where is Xerapeutics AB headquartered?

Xerapeutics AB's registered address is Vallvägen 4 A.

Xerapeutics AB

Key ratios

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on Xerapeutics AB

Key ratios

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on Xerapeutics AB